November 29, 2017


Ceeable to be Interviewed at the 2017 HITLAB Innovators Summit
-- Ceeable has developed and commercialized a digital tele-health technology for ophthalmology --

    SOMERVILLE, MA, November 29, 2017 /24-7PressRelease/ -- Ceeable, Inc. will be interviewed during the 2017 HITLAB Innovation Summit on November 29, 2017. Ceeable was a winner of the Innovators Summit in 2015. The purpose of the interview is to allow for other entrepreneurs to gain insight into the process of developing and commercializing a digital tele-health technology. The conference takes place at Columbia University in New York City from November 28-30, 2017.

About HITLAB
The 4th Annual HITLAB Innovators Summit brings together leaders in the life sciences, public health, medicine, technology, and design to discuss health issues and digital solutions in a three-day live event. The Summit offers a series of carefully curated talks, panels, and interactive collaboration opportunities to engage the most creative minds in both health and technology.

About Ceeable
Ceeable, Inc. is a leader in digital mobile health for ophthalmology. The Ceeable Visual Field Analyzer (CVFA) is a cloud-based digital platform used to detect and diagnose retinal disease. There are more than 300 million people worldwide that suffer from retinal disease. The Ceeable technology can reach more people worldwide than any currently available retinal assessment technology. Better patient management of eye disease will reduce healthcare systems costs and help prevent irreversible vision loss and blindness.

# # #


Contact Information:
Chris ADAMS
Ceeable
Somerville, MA
USA
Voice: 617-957-9858
Website: http://ceeable.com

Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release Newswire. We are unable to assist you with any information regarding this release. 24-7 Press Release Newswire disclaims any content contained in this press release. Please see our complete Terms of Use disclaimer for more information.
This News Release can be viewed online at: http://www.24-7pressrelease.com/press-release-service/447162